Ownership history in NATIXIS · 21 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in HAEMONETICS CORP (HAE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 29,600 | +29,599 | +2959900.0% | 0.01% | $1.4M | $48.74 |
| 2024 Q3 | UNCHANGED | 1 | — | 0% | 0.00% | $80 | $80.38 |
| 2024 Q2 | UNCHANGED | 1 | — | 0% | 0.00% | $83 | $82.73 |
| 2024 Q1 | REDUCED | 1 | -18,351 | -100.0% | 0.00% | $85 | $85.35 |
As of 2025 Q4 — sorted by position size